ArticleNPJ digital medicine2026
Leveraging large scale deep learning models for diagnosis and visual outcome prediction in retinitis pigmentosa.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multimodal prediction of visual improvement in diabetic macular edema using real-world electronic health records and optical coherence tomography images.medRxiv : the preprint server for health sciences · 2026Article
- Article
- From reference-genome prediction to causal generalization: sequence-to-function models for plant regulatory genomics.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Retinitis pigmentosa (RP) is an inherited progressive retinal degeneration that shows symptoms of night blindness, visual field loss, declining of vision and eventually, blindness. Currently, gene therapy and retinal prosthesis are available, but the indication for these treatments is limited. In this study, we report on the development of a diagnostic and prognostic model for RP based on large-scale deep learning (DL) models pre-trained with fundus images. The EfficientNetB4 model performed best in diagnosing RP with an AUC of 0.94. The diagnosis of RP with this model is superior in cases with good vision. For visual prognosis, we applied machine learning survival analysis to DL-derived image features and clinical metadata, using a strict patient-level split to avoid data leakage. The hybrid model combining imaging and clinical data outperformed models based on either modality alone, especially in female patients. Time-dependent AUC analysis showed that prognostic performance was highest between 500 and 1400 days after examination. SHAP-based interpretability analysis revealed that the features contributing to RP diagnosis and those associated with prognosis were distinct. While our findings demonstrate the added value of fundus images in visual outcome prediction, further validation using external and multi-center datasets is necessary for clinical translation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.